Nephurocare Pharma Private Limited

Nephurocare Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2010PTC062880 Incorporated 11 November 2010 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹7.08 Cr
▲ 17% YoY
Net profit · FY 2025
₹12.11 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹52.62 Lakh
EBITDA margin 7.4%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹2.2 Cr
Satisfied ₹1.1 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
21
Provident fund records

About Nephurocare Pharma Private Limited

Data last updated:

Nephurocare Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 November 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC062880. Its GSTIN is 24AADCN4484D1ZM (Gujarat).

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It was formerly known as Nerve Biosciences Private Limited. It is led by directors including Snehal Narendraprasad Vaishnav and Viral Narendrabhai Shah.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.08 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹12.11 Lakh (net margin 1.7%) and EBITDA of ₹52.62 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 10% over five years.

The company has about 21 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Nephurocare Pharma Private Limited. As per MCA filings, the company has open charges of ₹2.2 Cr and satisfied charges of ₹1.1 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending.

Nephurocare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0057440). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nephurocare.com.

Company details

CIN U24230GJ2010PTC062880
Registration Number 062880
Incorporation Date 11 November 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0057440
Key People
Snehal Narendraprasad Vaishnav Director Viral Narendrabhai Shah Director Sandip Kulkarni Sureshrav Director

Recognitions & Rankings of Nephurocare Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-01-0057440

Contact details

Nephurocare Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is nephurocare.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    nephurocare.com
  • Registered Address
    301 Gold Leaf Maradia Plaza Lane Behind Law College Off C.G. Road Navra, Ngpura, Ahmedabad, Gujarat, India – 380009
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Nephurocare Pharma Private Limited, buy the company report.

Comprehensive company report
Nephurocare Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Nephurocare Pharma operates one associated brand: Nephurocare Pharma Private Limited. Each brand links to its own profile.

BrandDescriptionWebsite
Nephurocare Pharma Private Limited
Medicines are supplied in renal, urology, and critical care sectors.nephurocare.com

Business activity

The main business activity of Nephurocare Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nephurocare Pharma Private Limited, buy the company report.

Financials of Nephurocare Pharma Private Limited

FY 2025 filings available

Nephurocare Pharma Private Limited reported revenue of ₹7.08 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹7.08 Cr ▲ 17%
Net profit · FY 2025
₹12.11 Lakh margin 1.7%
EBITDA · FY 2025
₹52.62 Lakh margin 7.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 19%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 21%
5 years · compounded
▲ 11%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 17% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹52.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.11 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.4%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nephurocare Pharma Private Limited, buy the company report.

Board of directors of Nephurocare Pharma Private Limited

Nephurocare Pharma has 7 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Snehal Narendraprasad VaishnavDirector04 Sep 201412 Years 2 MonthsCurrent
Viral Narendrabhai ShahDirector04 Sep 201412 Years 2 MonthsCurrent
Sandip Kulkarni SureshravDirector18 Sep 201412 Years 1 MonthsCurrent
Jashvant Patel Prahladbhai
Also directs: Fraternity of Gujarat Safe Chemists and Distributors Alliance Limited, Aiocd Pharma Limited, Ethics Medserve Private Limited and 3 more
Director10 Sep 201412 Years 1 MonthsCurrent
Shailesh Joshi RameshchandraDirector01 Apr 201511 Years 7 MonthsCurrent
Satyajit Indravadan BhattDirector01 Mar 201412 Years 8 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Nephurocare Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Gladje Pharmaceuticals Private Limited₹7.09 Cr (FY 2025)94.0%Jaipur, Rajasthan, India
Nephurocare Pharma Private Limitedthis company₹7.08 Cr (FY 2025)₹12.11 Lakh1.7%17.0%21Ahmedabad, Gujarat, India
Lyka Healthcare Limited₹7.07 Cr (FY 2020)-32.0%Bhiwandi, Maharashtra, India
Winsome Medicare Private Limited₹7.06 Cr (FY 2025)4.0%Gurugram, Haryana, India

To see the full peer comparison of Nephurocare Pharma Private Limited, buy the company report.

Auditor

Nephurocare Pharma Private Limited is audited by RAJIV SHAH & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAJIV SHAH & ASSOCIATESFY 2023108454W

Shareholding

The shareholding of Nephurocare Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nephurocare Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.2 Cr
Satisfied charges
₹1.1 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Oct 2023100819336Hdfc Bank Limited₹70 LakhOpen
15 Jun 2023100769132Hdfc Bank Limited₹1.5 CrOpen
28 Nov 2017100140522Others₹70.2 LakhSatisfied
01 Mar 2017100081335Others₹40 LakhSatisfied

To see the full charge records of Nephurocare Pharma Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nephurocare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Nephurocare Pharma Private Limited has a workforce of 21 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
21
Active EPFO establishments
1

GST

Nephurocare Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AADCN4484D1ZMGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Nephurocare Pharma Private Limited, buy the company report.

Recent activity

Nephurocare Pharma Private Limited has 12 board changes on record since 2012: 7 appointments and 5 cessations. The latest: Bijjala Kavitha ceased to be Director on 28 Apr 2017.

AGM
Nephurocare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nephurocare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 150.00 Lakh registered on 15 Jun 2023 with Charge ID 100769132 was modified on 12 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 70.00 Lakh with Charge ID 100819336 was registered on 04 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 100769132 was registered on 15 Jun 2023.
Charges
A charge registered on 28 Nov 2017 via Charge ID 100140522 with Others was fully satisfied on 15 Jun 2023.
Charges
A charge with Others of Rs. 70.20 Lakh registered on 28 Nov 2017 with Charge ID 100140522 was modified on 03 Nov 2022.
Charges
A charge with Others amounted to Rs. 70.20 Lakh with Charge ID 100140522 was registered on 28 Nov 2017.
Charges
A charge registered on 01 Mar 2017 via Charge ID 100081335 with Others was fully satisfied on 10 Aug 2017.
Ceased
Bijjala Kavitha ceased to be Director.
Charges
A charge with Others amounted to Rs. 40.00 Lakh with Charge ID 100081335 was registered on 01 Mar 2017.
Ceased
Jugal Satyajit Bhatt ceased to be Director.

11 earlier events are in the company report.

Frequently asked questions

Nephurocare Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 November 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC062880.

Nephurocare Pharma has 7 current directors:

The latest financial statements of Nephurocare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nephurocare Pharma is 24AADCN4484D1ZM, registered in Gujarat.

The CIN (Corporate Identification Number) of Nephurocare Pharma is U24230GJ2010PTC062880. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nephurocare Pharma has 4 court cases on record: 4 filed by the company. 1 is pending.

Nephurocare Pharma was incorporated on 11 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Nephurocare Pharma by revenue are Gladje Pharmaceuticals Private Limited, Lyka Healthcare Limited, Winsome Medicare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Bijjala Kavitha ceased to be Director on 28 Apr 2017. Jugal Satyajit Bhatt ceased to be Director on 13 Feb 2016. Nitinkumar Kantilal Patel was appointed as Director on 01 Apr 2015. Nephurocare Pharma has 12 board changes on record in total.

Yes, Nephurocare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0057440).

Nephurocare Pharma can be reached through the website nephurocare.com. Its registered office is in Ahmedabad, Gujarat, India.